Watch SynBioBeta2026 Live Anywhere, No Travel Needed
Visas. Travel costs. Time away from the lab or the office. Not everyone can make it to San Jose for #SynBioBeta2026 That's exactly why we built the livestream. 160+ sessions. 200+ speakers. Three days of Main Stage content streaming directly to your laptop, wherever you are in the world. The field is moving fast. AIxBio is not slowing down. You don't have to be in the room to be part of it, get access here: https://t.co/wqhHTSHixV
Nanophotonic Chips Finally Make the Proteome Visible
We sequence genomes and map transcriptomes with ease. Why is the proteome still invisible? Proteins are where biology actually happens. But until now, we have lacked the tools to read them at scale. @jendionne and her team are building nanophotonic chips that...
Vertical AI Beats Generic Models in Enzyme Engineering
Foundation models are powerful. They're also generic. And in industrial enzyme engineering, generic doesn't cut it. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK The industrial last mile of...
AI Learns From Millions of Genomes, Not Text
What if you could train a ChatGPT-style AI not on text from the internet, but on millions of genomes across all of life? Samuel King has spent his @Stanford PhD building exactly that. He'll be on the "Genome as a Canvas" panel...
AI-Driven Synthetic Evolution Accelerates Biological Design
Evolution is the most powerful optimization algorithm ever run. It just takes billions of years. Researchers are now rewriting the code. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here:...
Tech Giants Converge on AI‑Biology at SynBioBeta 2026
Silicon Valley's biggest tech players aren't just watching synthetic biology from a distance. They're showing up in person. This year at @SynBioBeta 2026, delegations from @Amazon, @Google, @Apple, @OpenAI, @Anthropic, @NVIDIA, and others are coming to San Jose to see what's...
Half of NMN Supplements Mislabelled, May Harm Users
David Sinclair's research helped turn NMN into a billion-dollar industry. Now he says roughly half the products don't contain what's on the label - and some contain ingredients that could harm you Firstly, NMN (nicotinamide mononucleotide) is a molecule that converts to...
Food, Not Pills, May Solve Obesity and Heart Disease
The next breakthrough in managing obesity, heart disease, or cognitive decline might not come from a pill. It might come from your food. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your...
AI‑Designed Enzymes Accelerate Corporate Partnerships at SynBioBeta
@SynBioBeta isn't just where startups find investors. It's where Fortune 500 companies find their next technology partner. @IFF is one of the world's largest flavor, fragrance, and biosciences companies, with over $11 billion in revenue and a century-long track record of...
Biology’s Data Gap: Making Lab Results AI-Ready
Biology generates enormous amounts of data. Almost none of it is ready for AI. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK Most experimental infrastructure was built for individual...
Aging Mechanisms Are Now Engineerable, Says SynBioBeta
Aging isn't just inevitable decline. It's a set of biological systems that are starting to look engineerable. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK DNA damage accumulates. Protein...
Beyond CAR T: Programmable Immune Cells Shaping Future Therapies
CAR T cells cured patients who had no other options. That was just the opening move. #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ1GbK The next generation of T...
Nabla Bio Secures Seed Funding Directly at Conference
Some companies raise a seed round. Nabla Bio had one built at a conference. https://t.co/1xmbmuqA8p
SynBioBeta Fuels Boom Capital’s Top Biotech Deals
@SynBioBeta draws one of the densest concentrations of biotech investors of any conference in the world. So what keeps them coming back? Celestine “Cee Cee” Schnugg has the answer. Cee Cee is the Founding Managing Partner of Boom Capital, an early-stage deep...
CRISPR Advances Outpace Ethics in Germline Editing Debate
In 2018, He Jiankui edited the genomes of two human embryos, brought them to term, and went to prison for it. The babies are now children. We don't know how they're doing. Seven years later, base editing and prime editing can...
Israel's SynBio Surge: CEOs Reveal Scaling Success
Israel has built one of the most concentrated synbio ecosystems outside the US. The country's National Bioconvergence Program, run through the Israel Innovation Authority, is specifically designed to close the gap between lab-scale innovation and commercial biomanufacturing. This session at @SynBioBeta 2026...
Scientists Reverse Mouse Aging by 75%, Promising Human Breakthroughs
Dr. David Sinclair just dropped a two-hour masterclass on Tom Bilyeu's podcast. He shared 10 mind-blowing insights on how to reverse biological age in animals (and why it should work in humans too). 1) They already reversed a mice's age by 75%...
AI-Designed Enzymes Poised to Replace Petrochemicals in Everyday Products
The detergent you use. The fabric on your Gore-Tex jacket. The fragrance in your shampoo. For a century, making these products meant petrochemicals and harsh industrial chemistry. AI protein design is changing the underlying process. @ArzedaCo builds custom enzymes for real...
Sidewinder Cuts DNA Assembly Errors to One‑in‑Million
Biology's source code is DNA. For 40 years, we've been able to read it. Writing it, especially long, complex sequences, is still painfully slow, expensive, and error-prone. Current DNA assembly methods fail about once every 10 to 30 connections. Kaihang Wang's lab...
Illuminating the Dark Proteome: Protein Sequencing’s Next Frontier
The Human Genome Project mapped our DNA. We still can't read most of our proteins. There are billions of proteins in biology we've never sequenced: no function known, no structure solved, no role in disease understood. They're not hypothetical, they're real...
Design‑First Protein Engineering Delivers Round‑One Success
Protein engineering has a dirty secret: most of the work is in the lab, not the algorithm. You design, you test, most variants fail, you iterate for months. Scala Biodesign's bet is that the design layer can do most of that...
Scaling Bio‑Products: Funding, Forecasting, and Partnerships
Getting from pilot plant to commercial scale is where most bio-based products die. The science works. The economics don't. Or the capital isn't there. Or the supply chain can't handle the volume. This session at @SynBioBeta 2026 brings together people who've actually...
Human‑scale Data Aims to Close Drug Trial Gap
90% of drugs that enter clinical trials fail. A big part of why: the models they're based on weren't trained on human biology. Mouse data, non-representative cell lines, sparse perturbation coverage. The gap between in silico predictions and what actually happens...
AI-Driven CRISPR‑GPT Enables Fully Autonomous Lab Experiments
A junior researcher walks up to a CRISPR experiment they've never run before. An AI agent has already decomposed the workflow, selected the guide RNAs, anticipated failure modes, and drafted the protocol. They run it successfully on their first attempt. That's not...
From Static Snapshots to Dynamic Protein Modeling
AlphaFold solved protein structure prediction. That's a snapshot. But biology isn't static. Proteins flex, shift, and interact across time. Drug targets have multiple conformations. Cells don't act alone. The next hard problem is capturing that motion, and building models that reflect...
Turning Down $10M Led to GitLab’s IPO Success
Sid Sijbrandij, co-founder of GitLab, was offered $10 million for his company. His dad said sell. His accountant said sell. His response: 'I really like working, so I don't mind working. And I think we can do better Six years later,...
Synthetic Biology Localizes Drug Production, Ending Fragile Supply Chains
Most pharmaceutical APIs still travel thousands of miles through fragile global supply chains before they reach a patient. COVID and the Russia-Ukraine war showed exactly what that fragility costs. Synthetic biology offers a different model: program cells to manufacture the molecules in...
30 Top Media Leaders at SynBioBeta Can Make You Viral
📰 𝟯𝟬 𝗝𝗼𝘂𝗿𝗻𝗮𝗹𝗶𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗿𝗲𝘀𝘀 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗦𝘆𝗻𝗕𝗶𝗼𝗕𝗲𝘁𝗮 𝟮𝟬𝟮𝟲 𝘄𝗵𝗼 𝗰𝗼𝘂𝗹𝗱 𝗺𝗮𝗸𝗲 𝘆𝗼𝘂𝗿 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗴𝗼 𝘃𝗶𝗿𝗮𝗹 📰 With a combined reach of 500M+ monthly visitors, the journalists in the room at @SynBioBeta know how to get your work in front...
IPSC Tissues Supply Causal Data to Power Simulations
A general-purpose biological simulator, one that can predict how the human body responds to any intervention, isn't blocked by compute. It's blocked by data. Not data in general. Causal, human-relevant data. The kind where molecular interactions actually produce functional outcomes you...
Science Enables Viable Alternative to Inefficient Meat Production
For 12,000 years, we've been cycling crops through animals to make meat. It's one of the least efficient production systems on Earth, and also one of the most consequential: climate, deforestation, antibiotic resistance, pandemic risk. @BruceGFriedrich has spent a decade building the...
AI Designs Lab-Ready Antibodies From Text Prompts
Drug discovery has always meant finding. Screening libraries. Keeping what survives. Semiconductors don't work that way. Neither do aircraft. You design them computationally before anything gets built. @saakohl left @GoogleDeepMind after co-developing AlphaFold2 to do the same thing for biologics. @LatentLabs_ Latent-X2...
Today's Teen Could Become First 150‑year‑old
David Sinclair says the first person to live to 150 is a teenager who's alive today. He's taken flak from colleagues for years over this prediction. He doesn't care. He still stands by it. "The first person to live to 150 has...
AI Models Map Worm Brain, Scale to Synthetic Biology
The C. elegans nervous system has exactly 302 neurons and 7,000 synaptic connections. Scientists have had the full wiring diagram since 1986. What they haven't had: a computational model that captures how those neurons actually develop and wire themselves up. Eric Wasiolek...
Data, Not Models, Limits AI in Biology
The biggest bottleneck in AI for biology isn't models. It's data. @BerkeleyLab is building the infrastructure to fix that: integrated multi-omics datasets, queryable data lakehouses across data types, and high-quality annotated training data for modeling dynamic biological systems. This is DOE-funded, national-scale...
RNA‑seq No Longer a Bottleneck: 3‑day Turnaround
What if sequencing wasn’t the bottleneck anymore? #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ18mc @plasmidsaurus is removing friction from RNA-seq. 3-day turnaround in Europe. No dry ice. This is...
Physics‑Based Sensors and AI Transform Bioreactor Monitoring
Bioreactors are billion-dollar processes monitored by pH probes and dissolved oxygen sensors. That's like running a semiconductor fab with a thermometer. @schmidtsciences is adapting physics tools that don't usually touch biology: fluorescent nanodiamonds, single-cell Raman spectroscopy, and optical frequency combs that...
Genetically Switched Microbes Aim to Cut Synthetic Nitrogen Use
Nitrogen fertilizer feeds 4 billion people. It also uses 2% of global energy to produce and loses nearly half of what's applied to runoff. Biology has promised a fix for decades. The problem: engineered microbes that make nitrogen can't also compete...
Continuous Fermentation Cuts Costs, Beats Traditional Bioreactors
The biomanufacturing bottleneck isn't biology. It's economics. Building bigger bioreactors doesn't fix unit costs. https://t.co/2RAcw704uk's bet: continuous fermentation decouples growth from production, keeps cells in an ultra-productive state for weeks, and runs like a conveyor belt instead of a batch process. ...
One Engineer + AI Agents Replace Seven-Person Teams
Sid Sijbrandij, the co-founder of GitLab, just said: "One developer with parallel AI agents will outproduce an entire team of seven." And at his new company Kilo, that's already the standard. He has 20 engineers. Each one manages multiple AI agents across...
Crossing the SynBio Valley of Death with Proven Solutions
Most synbio companies die between "works in the lab" and "works at scale." Freedom-to-operate issues, process robustness, CMC readiness. The valley of death is real and it swallows good science. @IngenzaLtd has been helping teams cross it for 20 years. Leonardo Magneschi...
DeepSeqAI Trains on Function to Future‑proof Biologics
Most AI protein tools are trained on structure. DeepSeqAI trains on function. They're running billions of experimental protein-protein interactions through their platform to map biologics against viruses, immune receptors, and the entire human proteome. The goal: candidates that hold up against...
One Gene Therapy Platform Could Cure Obesity and More
Eric Kelsic makes the compelling case on using gene therapy technology to eventually treat common diseases, like obesity: “Fundamentally, we all share the same genetics." Because our bodies run on the same genetic blueprint, a disease - whether common or rare -...
A Decade of DNA Innovation Powers AI‑Biology Convergence
Ten years ago, Emily Leproust had an idea to rewrite how DNA gets made. Most people thought it wouldn't work. Today, Twist Bioscience is the infrastructure layer for biotech and pharma worldwide. At SynBioBeta 2026, she's on the main stage with John...
Memory, Not Models, Limits AI-Driven Scientific Discovery
The biggest bottleneck for agentic AI in science isn't the model. It's memory. What was tried. What failed. Why decisions were made. That institutional knowledge lives in scattered notebooks, emails, and people's heads — and most AI tools have no access to...
P&G Brings Biotech Ingredients to Mass‑market Consumer Products
P&G doesn't move on new ingredients unless the science is bulletproof and the consumer performance is there. They're moving on biotech. Three R&D leaders from Procter & Gamble are at SynBioBeta 2026 to talk about how bio-derived ingredients are making it into...
AI‑Designed Enzymes Break Evolution’s Limits for Biomanufacturing
Nature never designed enzymes for industrial manufacturing. It designed them to survive. That mismatch is one of the biggest bottlenecks in biomanufacturing — and most of the industry has been working around it with incremental fixes for decades. Matthew Thompson from Biomatter...
Cell‑free DNA Manufacturing Eliminates Cloning Bottlenecks
Your DNA synthesis workflow is probably slowing you down more than you think. Cloning introduces delays, contamination risk, and hard limits on what you can build. Most of the field is still living with these constraints — even as mRNA therapeutics,...
Self‑immunized Man’s Blood Yields Universal Antivenom
A truck mechanic from Wisconsin spent 18 years injecting himself with venom from the world's deadliest snakes. 700 doses. 200+ bites. He taught himself immunology from a textbook. His name is Tim Friede. His blood may end up saving hundreds of...
NMN Daily Restores NAD, Supports Healthy Aging
David Sinclair takes 1 gram of NMN every single day. Here's why. As you age, your body loses up to 50% of a molecule called NAD. NAD is a molecule that acts like fuel powering your sirtuin genes - the genes responsible...
40 AI‑Biology Leaders Converge at SynBioBeta 2026
40 of the biggest names in AI x Biology will be on stage at @SynBioBeta May 4–7 in San Jose, California. Get your tickets here: https://t.co/8abYWJ1GbK Marc Tessier-Lavigne (@Xaira_Thera), Kim Branson (@GSK ). @GabriCorso (Boltz). Peter Clark (@novonordisk ). Dave Hallett (@RecursionPharma). Ashoka...